Company intelligence / Profile preview

Biopharma PEG Scientific

Watertown, Massachusetts, United States

Ownership: Private
Employees: ~159
Development stage: Other

Overview

Biopharma PEG Scientific (Biochempeg) is a biotechnology supplier and CMO specializing in the manufacturing and supply of high-purity polyethylene glycol (PEG) derivatives, linkers, and excipients. They provide enabling technologies for drug delivery systems, including Antibody-Drug Conjugates (ADCs), Lipid Nanoparticles (LNPs) for mRNA drugs, and hydrogels, serving the biotech, pharma, diagnostics, and research sectors globally. They do not develop therapeutics directly but support pharmaceutical R&D and manufacturing with their specialized chemical products.

Modalities: Polymer-drug conjugate therapySmall moleculeAntibody-drug conjugateLipid nanoparticle delivery therapyHydrogel-based drug delivery therapy
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Biopharma PEG Scientific.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biopharma PEG Scientific.

Explore the full profile